Birmingham hospital trust gains funding for new medical technology co-operative

Posted on 6 September 2017 (Permalink)

University Hospitals Birmingham NHS Foundation Trust (UHB) has successfully been awarded funding to establish a co-operative, bringing together patients, clinicians, researchers, commissioners and industry to develop new medical technologies and provide evidence on commercially-supplied in vitro diagnostic (IVD) tests. 

Following the announcement of the Secretary of State for Health, the Rt. Hon. Jeremy Hunt, of £14.25m funding to support 11 NIHR Medtech and In vitro diagnostic Co-operatives nationally, UHB will now establish the NIHR Trauma Management MedTech Co-operative.

Funding will be provided over five years for leading NHS organisations to develop the NIHR Medtech and In Vitro Diagnostic Co-operatives, which aim to build expertise and capacity in the NHS.  

The NIHR Trauma MedTech Co-operative at UHB will have a specific focus on medical devices and technology in the trauma management field, led by Dr Tom Clutton-Brock. The award will allow UHB to build on five successful years of working with the public, clinicians, academics and industry which has driven innovation in the medtech sector, as part of the NIHR Healthcare Technology Co-Operatives initiative.

UHB is part of Birmingham Health Partners (BHP), a strategic alliance between the trust, the University of Birmingham and Birmingham Women’s and Children’s NHS Foundation Trust. BHP focuses on the identification, adoption and spread of innovation and best practice through the alignment of healthcare delivery, research and training. It aims to improve healthcare, contribute to the local economy through job creation and inward investment into the biomedical sector and increase public engagement and education about biomedicine and clinical research.

Dr Louise Wood, Director of Science, Research and Evidence at the Department of Health, said: “The funding received by the eleven NIHR Medtech and In vitro diagnostic Co-operatives will make a real difference to patients’ lives and provide a focal point for the medtech and in vitro diagnostic industries to develop new technologies and generate the evidence needed by the NHS to support the uptake of new tests.”

The commencement of the NIHR Trauma MTC will coincide with the launch of the Medical Devices Testing and Evaluation Centre, financially supported by the European Regional Development Fund in Birmingham in January 2018, which will offer a unique opportunity to facilitate evaluation of products for industry in a ‘real-life’ environment, involving appropriate clinical and technical staff.

You can read the NIHR’s announcement here and find further details of the new NIHR Medtech and In vitro diagnostic Co-operatives here.